Takeda has announced the appointment of Julie Kim as the successor to Christophe Weber, effective from June 2026.

Prioritising US health, Trump has already frozen the supply of HIV and malaria medication aid to endemic countries.

The potential secretary for Health and Human Services has been forced to defend his previous anti-vaccine stances at his ...

Acellera and Psivant have announced a strategic research partnership aimed at developing computational drug discovery ...

Lyndra Therapeutics has announced the immediate appointment of Adam Sayer as its new president and CEO, succeeding Jessica ...

The deal includes an upfront payment of $250m, with the potential for an additional $752.5m in milestone payments.

AstraZeneca and Daiichi Sankyo ’s antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) has received approval from ...

The new indication makes Ozempic the first glucagon-like peptide-1 receptor agonist (GLP-1RA) available for people with T2D ...

Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

A proposed ban on PFAS chemicals is being challenged over concerns about potential supply chain disruption in the ...

AB2 Bio has made an option and licensing agreement with Nippon Shinyaku, granting the latter the option to commercialise ...

ITM Radiopharma’s Phase III trial of its targeted radiotherapeutic for patients with Grade 1 or 2 gastroenteropancreatic ...